---
title: Efficacy of albumin use in decompensated cirrhosis and real-world adoption
  in Australia
date: '2024-09-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39301299/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240920192845&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The current treatment approach to patients with liver cirrhosis relies
  on the individual management of complications. Consequently, there is an unmet need
  for an overall therapeutic strategy for primary and secondary prevention of complications.
  The clinical potential of long-term albumin infusions supported by recent clinical
  trials has expanded its indications and holds promise to transform the management
  and secondary prevention of cirrhosis-related complications. This renewed interest
  ...
disable_comments: true
---
The current treatment approach to patients with liver cirrhosis relies on the individual management of complications. Consequently, there is an unmet need for an overall therapeutic strategy for primary and secondary prevention of complications. The clinical potential of long-term albumin infusions supported by recent clinical trials has expanded its indications and holds promise to transform the management and secondary prevention of cirrhosis-related complications. This renewed interest ...